Recent developments and innovations in gastric cancer

• Published in: World journal of gastroenterology : WJG Vol. 22; no. 17; pp. 4307 - 4320
• Main Authors: Mihmanli, Mehmet, Ilhan, Enver, Idiz, Ufuk Oguz, Alemdar, Ali, Demir, Uygar
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Inc 07.05.2016
• Subjects: Combined Modality Therapy; Cytoreduction Surgical Procedures; Gastrectomy; Gastric Mucosa - surgery; Gastric;Cancer;Endoscopic; Gastroscopy; Humans; invasive; Lymph Node Excision; Minimally Invasive Surgical Procedures; mucosal; Neoplasm Staging; resection;Endoscopic; resection;Minimally; Review; Robotic Surgical Procedures; Stomach Neoplasms - pathology; Stomach Neoplasms - therapy; submucosal; surge; Neoadjuvant chemotherapy; Endoscopic submucosal resection; Minimally invasive surgery; Human epidermal growth factor receptor 2; Endoscopic mucosal resection; Gastric; Cancer
• ISSN: 1007-9327; 2219-2840; 2219-2840
• DOI: 10.3748/wjg.v22.i17.4307

Gastric cancer has an important place in the worldwide incidence of cancer and cancer-related deaths. It can metastasize to the lymph nodes in the early stages, and lymph node metastasis is an important prognostic factor. Surgery is a very important part of gastric cancer treatment. A D2 lymphadenectomy is the standard surgical treatment for c T1N+ and T2-T4 cancers, which are potentially curable. Recently, the TNM classification system was reorganized, and the margins for gastrectomy and lymphadenectomy were revised. Endoscopic, laparoscopic and robotic treatments of gastric cancer have progressed rapidly with development of surgical instruments and techniques, especially in Eastern countries. Different endoscopic resection techniques have been identified, and these can be divided into two main categories: endoscopic mucosal resection and endoscopic submucosal dissection. Minimally invasive surgery has been reported to be safe and effective for early gastric cancer, and it can be successfully applied to advanced gastric cancer with increasing experience. Cytoreductive surgery and hypertherm?c intraper?toneal chemotherapy were developed as a combined treatment modality from the results of experimental and clinical studies. Also, hyperthermia increases the antitumor activity and penetration of chemotherapeutics. Trastuzumab which is a monoclonal antibody interacts with human epidermal growth factor(HER) 2 and is related to gastric carcinoma. The anti-tumor mechanism of trastuzumab is not clearly known, but mechanisms such as interruption of the HER2-mediated cell signaling pathways and cell cycle progression have been reported previously. H. pylori is involved in 90% of all gastric malignancies and Japanese guidelines strongly recommend that all H. pylori infections should be eradicated regardless of the associated disease. In this review, we present innovations discussed in recent studies.